Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 61404-41-9 | MDL No. : | MFCD19703876 |
Formula : | C7H7ClN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WTBUDFWPROPPOW-UHFFFAOYSA-N |
M.W : | 202.60 | Pubchem ID : | 12338784 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.15 |
TPSA : | 72.31 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.43 cm/s |
Log Po/w (iLOGP) : | 1.27 |
Log Po/w (XLOGP3) : | 1.56 |
Log Po/w (WLOGP) : | 1.01 |
Log Po/w (MLOGP) : | 0.73 |
Log Po/w (SILICOS-IT) : | 1.23 |
Consensus Log Po/w : | 1.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.22 |
Solubility : | 1.21 mg/ml ; 0.00599 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.69 |
Solubility : | 0.415 mg/ml ; 0.00205 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.18 |
Solubility : | 1.34 mg/ml ; 0.00661 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.29 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1591827-16-5 ]
Methyl 6-chloro-3-methoxypyridazine-4-carboxylate
Similarity: 0.95
[ 612834-90-9 ]
Ethyl 6-chloropyridazine-4-carboxylate
Similarity: 0.89
[ 50681-26-0 ]
6-Chloro-3-hydroxypyridazine-4-carboxylic acid
Similarity: 0.89
[ 34127-22-5 ]
Ethyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.83
[ 286946-24-5 ]
Methyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.80
[ 50681-26-0 ]
6-Chloro-3-hydroxypyridazine-4-carboxylic acid
Similarity: 0.89
[ 7251-53-8 ]
Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate
Similarity: 0.58
[ 5754-17-6 ]
4,5-Dimethylpyridazine-3,6-diol
Similarity: 0.52
[ 5754-18-7 ]
1,2-Dihydro-4-methyl-3,6-pyridazinedione
Similarity: 0.52
[ 1591827-16-5 ]
Methyl 6-chloro-3-methoxypyridazine-4-carboxylate
Similarity: 0.95
[ 612834-90-9 ]
Ethyl 6-chloropyridazine-4-carboxylate
Similarity: 0.89
[ 34127-22-5 ]
Ethyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.83
[ 286946-24-5 ]
Methyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.80
[ 7251-53-8 ]
Ethyl 3-hydroxy-1H-pyrazole-4-carboxylate
Similarity: 0.58
[ 1591827-16-5 ]
Methyl 6-chloro-3-methoxypyridazine-4-carboxylate
Similarity: 0.95
[ 612834-90-9 ]
Ethyl 6-chloropyridazine-4-carboxylate
Similarity: 0.89
[ 50681-26-0 ]
6-Chloro-3-hydroxypyridazine-4-carboxylic acid
Similarity: 0.89
[ 34127-22-5 ]
Ethyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.83
[ 286946-24-5 ]
Methyl 3,6-dichloropyridazine-4-carboxylate
Similarity: 0.80